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genotype, viral mutations, level of HBV replication), host
factors (gender, age, and immune status), and exogenous
factors such as concurrent infection with other hepatotropic
viruses or alcohol.this study was conducted to evaluate
HBsAg persistence, related risk factors of HBV infection and
detect of HBeAg positive cases and abnormal liver enzyme
tests among chronic HBV carriers in Kashan.
Methods: This descriptive study was performed in HBsAg
positive blood donors. They were invited to retest HBsAg
.A questionnaire consisting demographic and history of risk
factors of HBV infection were ﬁlled by interviewing and then
5cc blood was taken and HBsAg was measured by ELISA
method. Who had HBsAg positive test without history of
acute hepatitis during the previous year, were known as
chronic carriers. and HBeAg, hepatic aminotranferases and
alkaline phosphatase were measured.
Results: Of 150 HBsAg positive blood donors 124(83.7%)
were male and 26(17.3%) female. Persistence and clear-
ance of HBsAg was seen in 132(88%) and18(12%). No
signiﬁcant statistical correlation between sex, age,marital
status, history of icther, endoscpy, tattoo. transfusion, with
persistence of HBsAg was found. In 132 HBsAg +chronic car-
riers the prevalence of HBeAg positive cases was 18.2%.
There was abnormal aminotransferase level including: 35
(26.3%)AST,16(12%)ALT,26(19.5%)ALKP Signiﬁcant statistical
correlation was seen between ALT and HBeAg but there was
no statistical correlation between AST and ALKP with HBeAg.
Conclusion: Considering the lower chance of clearance of
HBsAg and detect of correlation between HBeAg positive and
abnormal ALT,and also detect of suspected cases of chronic
hepatitis, follow up seems to be essential in HBeAg positive
cases.
doi:10.1016/j.ijid.2010.02.2001
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Positive association of high risk behaviors and Hepatitis B
infection
A. Nejatizadeh, F. Abedi ∗, A. Madani
Hormozgan university of Medical sciences, Bandar Abbas,
Iran, (Islamic Republic of)
Background: Hepatitis B is one the most infectious dis-
eases, without seasonal distribution, accounting for more
than one million deaths annually due to chronic hepatitis,
cirrhosis and hepatocellular carcinoma. We aimed to inves-
tigate the seroprevalence of the HBV infection in Bandar
Abbas, Iran and determine the association of respective risk
factors with its occurrence.
Methods: We conducted a cross sectional community-
based study of 1152 apparently healthy individuals aged
8—65 years for the serological HBsAg screening. A standard
questionnaire was administered to all subjects. Unpaired t-
test for continuous data and the #2 test for categorical data
were performed.
Results: A total of 1152 individuals were assessed for
hepatitis B surface antigen (HBsAg), which was 2.1% in over-
all. There was no signiﬁcant difference between males and
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emales with respect to HBsAg seropositivity (male, 2.2%
s female, 2.1%, P > 0.05). Singles showed a prevalence of
.7%, while HBsAg seropositivity in married participants was
.3%. Subjects with tattooing practices reﬂected signiﬁcant
igher prevalence (7.5%) compared to those without tat-
ooing (1.7%, P < 0.0002). History of drug abuse remained
igniﬁcantly associated with HBsAg seropositivity (4.9% vs.
.4%, P < 0.0001).
Conclusion: HBsAg seropositivity was found 2.1%. High
isk behaviors associated signiﬁcantly with seroprevalence
f HBsAg. Of these, tattooing emerged more crucial com-
ared to the risk factors identiﬁed in out in other regions.
oi:10.1016/j.ijid.2010.02.2002
3.021
iodynamics of HCV infection in haemodialysis patients in
ahang
. Mustafa ∗, M.S. Abdul Majid, H.A. Binti Hamzah, M.H. bin
asmaini
Faculty of Medicine, International Islamic University
alaysia, Kuantan, Pahang, Malaysia
Background: Hepatitis C is a global disease, WHO has
escribed it as a ‘‘viral time bomb’’. In Malaysia, the sero-
revalence is 1.6%. HCV infection is frequent in patients
ndergoing maintenance haemodialysis, with prevalence
etween 8 and 10%. Hepatitis C has an adverse effect on
oth patient and graft survival in those who get renal trans-
lants. There are relatively scarce reports on the natural
uctuation in viral load and alpha interferon (&-IFN) level
n patients on chronic hemodialysis.
Methods: A longitudinal short-term three months study
here 27 chronic hemodialysis patients infected with known
CV genotypes were recruited from seven hemodialysis cen-
ers in Pahang. Serum samples were collected monthly,
oth pre- and post-hemodialysis sessions, over a period of
hree months. Viral RNA was extracted from serum using
IAamp Viral RNA Extraction kit (Qiagen). The HCV viral load
as measured using one step reverse transcriptase qPCR
Applied Biosystems) targeting the 5‘HCV non-coding region.
he serum &-IFN level was measured using commercial ELISA
it (Amersham, UK). Six biochemical liver function tests
AST, ALP, TP, albumin, ALT and TB) were also done for all
re-hemodialysis samples.
Results: All patients showed persistant low level viral
oad that varied signiﬁcantly over the study period
P = 0.001). HCV genotype 1 viral load was signiﬁcantly
igher than that of genotype 3. The difference between
re- and post-haemodialysis viral load was statistically
nsigniﬁcant. No signiﬁcant correlation between viral load
nd liver function status was noted. No correlation was
bserved between pre-haemodialysis serum &-IFN level and
rehaemodialysis viral load. The difference between pre
nd post-haemodialysis plasma &-IFN levels was statistically
nsigniﬁcant.
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iral load variation in three batches of sera taken one
onth apart.
Conclusion: HCV infected haemodialysis patients expe-
ience signiﬁcant ﬂuctuation in viral load with time but no
orrelation with biochemical evidence of liver injury. HCV
enotype 1 is associated with higher viral load as compared
o genotype 3. Single-step rt qPCR assay has the potential
or rapid HCV genotyping.
oi:10.1016/j.ijid.2010.02.2003
3.022
uns test and linear trend test of the time series of pri-
ary hepatocellular carcinoma mortality in Haimen City,
969—2007
.-X. Huang ∗, H.-B. Lu, W.-Y. Lin
Haimen City Center for Disease Prevention and Control,
iangsu Province, Haimen, China
Background: To evaluate the trend and contributing fact-
rs of time series changes of primary hepatocellular carcin-
ma (HCC) mortality between 1969 and 2007 in Haimen City.
Methods: A ﬁve-year retrospective survey was conducted
n Haimen City in 1973 to verify the cause of death among
ll city population between 1969 and 1973. The birth/death
eporting system was also established and was deﬁned as
ne of the nation’s pilot city for vital statistics by Ministry of
ealth and Ministry of Public Security. In 2006 it was accep-
ed by the International Union Against Cancer (UICC) as a
ember institute. This paper describes the time series chan-
es of HCC mortality in Haimen City between 1969 and 2007.
uns test was performed as stability test for the time series
nd linear trend test was performed as signiﬁcance test.
Results: HCC mortality increased from 33.18 per 100,000
n 1969 to 49.32 per 100,000 in 1979, with an annual increas-
ng rate of 4.04%. Between 1979 and 1989 the mortality
ncreased from 49.32 to 70.64 per 100,000, with an annual
ncreasing rate of 3.66%. Between 1989 and 1999 the mor-
ality decreased from 70.64 to 54.94 per 100,000, with an
nnual increasing rate of -2.28%. Between 1999 and 2007 the
ortality decreased from 54.94 to 50.09 per 100,000, with
n annual increasing rate of -1.15%. The runs test showed
n instable time series, and the linear trend test indicated
statistical signiﬁcant decreasing trend of HCC mortality
ince 1990. It is unlikely that this decreasing trend is caused
y random.
u
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Conclusion: The decreasing trend of HCC mortality in
aimen City since 1990 is related with the intervention of
nvironmental factors including ‘changing drinking water,
hanging staple food and prevention of HBV infection’ as
ajor components.
oi:10.1016/j.ijid.2010.02.2004
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redictive factors for sustained virological response in the
reatment of patients with chronic hepatitis C
. Svirtlih1,∗, D. Delic1, J. Simonovic1, A. Radovanovic1,
. Mitrovic1, L. Nikitovic1, E. Gvozdenovic1, S. Zerjav1, I.
oricic2
Clinic for Infectious and Tropical Diseases Clinical Centre
f Serbia, Belgrade, Serbia
Institute for Pathology, Medical Faculty University of Bel-
rade, Belgrade, Serbia
Background: The goal of antiviral therapy in patients with
hronic hepatitis C is to prevent progression of the dis-
ase. The most important treatment response is the absence
f viral RNA six months after discontinuation the therapy,
eﬁned as the sustained virological response (SVR). Success-
ul therapy depends on many factors that are in association
ith the virus itself and/or infected person. The aim of
he investigation was identifying some characteristics of the
atients and hepatitis C virus as pre-treatment predictive
actors for achieving SVR.
Methods: Total of 364 treatment-naïve patients was
nrolled in the study (60.4% were males; age from 16 yr-
5 yr, mean 42.18, SD± 11.71). Liver cirrhosis had 21.7%
f patients. Patients were treated with standard doses of
egylated interferon alpha and ribavirin during 6 to 12
onths depending on the genotype in the period from Jan-
ary, 2004 to January, 2009. Source of infection was blood
ransfusion, intravenous drug abuse, accidental injury and
nknown in 26.5%, 19.5%, 12%, and 42% of patients, respec-
ively. Genotype distribution revealed genotype 1, 3, and
in 56.8%, 26.7% and 5% of patients, respectively. The
inority of patients had genotype 2 and/or mixed genotypes
1b3a, 1b4). Detection and quantiﬁcation of viral RNA with
ommercial assay (Cobas Amplicor HCV Monitor v2, Roche
olecular Systems) was evaluated before treatment, after
reatment and six months later. Electronic data base (SPSS
or Windows V11.0) was used for statistical analysis.
Results: Total of 82.8% of patients were negative (HCV
NA< 50 IU/mL) after treatment while SVR was achieved
n 68.8% of patients. Binary logistic regression analysis
evealed intravenous drug abuse (p = .005) and genotype 3
p = .003) as positive, whereas age older than 40 (p = .000),
resence of cirrhosis (p = .039), and genotype 1 (p = .000)
ere negative predictor factors for SVR. In multivari-
te analysis, age older than 40 (p = .001) and genotype 1
p = .000) were signiﬁcant variables (Exp(B) = .351 vs. .233).
Conclusion: Successful virological response to therapy is
xpected in patients with genotype 3 and intravenous drug
sers. Presence of genotype 1 is the most important negative
redictor for treatment of patients with chronic hepatitis C.
oi:10.1016/j.ijid.2010.02.2005
